CTLA4 and head and neck squamous cell carcinoma: This study explored the prognostic significance of CTLA-4 expression in paraffin-embedded HNSCC tissue samples, contributing to the growing body of research that positions CTLA-4 as a pivotal target for immunotherapy [8,9].